The pet care industry is growing, providing IDEXX with significant growth opportunities. Check out why I rate IDXX stock as a ...
IDEXX Laboratories, Inc. develops ... It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays ...
Idexx Laboratories (IDXX) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $2.40 per share. This compares to earnings of $2.32 per share a year ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback